Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
879 9 |
Ultima descărcare din IBN: 2024-02-25 19:03 |
Căutarea după subiecte similare conform CZU |
616.24-036.12-07-085 (1) |
Patologia sistemului respirator. Tulburări ale organelor de respiraţie (757) |
SM ISO690:2012 ГИКАВЫЙ, Виктор, КЛЮЕВА, Елена, ПОВЕТКИН, Сергей, БАЧИНСКИЙ, Николай, ПОДГУРСКИ, Лилия, ЦУРКАН, Лучия, ПОЛЬШАКОВА, Ирина, КИАНУ, Марин. Фармакоэпидемиологическое исследование бронходилататоров при хронической обструктивной болезни легких в г. Кишиневe и г. Курскe. In: Revista de Ştiinţă, Inovare, Cultură şi Artă „Akademos”, 2019, nr. 2(53), pp. 74-82. ISSN 1857-0461. DOI: https://doi.org/10.5281/zenodo.3364337 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţă, Inovare, Cultură şi Artă „Akademos” | ||||||
Numărul 2(53) / 2019 / ISSN 1857-0461 /ISSNe 2587-3687 | ||||||
|
||||||
DOI:https://doi.org/10.5281/zenodo.3364337 | ||||||
CZU: 616.24-036.12-07-085 | ||||||
Pag. 74-82 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The pharmacoepidemiological study demonstrated that bronchodilator preparations were prescribed for the treatment of chronic obstructive bronchopneumopathy in accordance with national and international recommendations. Salbutamol or fenoterol was administered in case of disease exacerbations. While long-acting beta2-adrenomimetics, M-colinoblocks and inhaled glucocorticoids were used in the treatment of stable forms of chronic obstructive pulmonary disease. Fixed combinations such as beta-2-adrenomimetics with long-lasting M-colinoblocks, long-lasting beta-2 adrenomimetics with inhaled glucocorticoids, beta-2-adrenomimetics with long-lasting M-colinoblocks with inhaled glucocorticoids were also used. These drugs were prescribed as original or generic preparations, depending on availability in the pharmaceutical market. |
||||||
Cuvinte-cheie pharmacoepidemiological study, bronchodilator, chronic obstructive bronchopneumopathy, studiu farmacoepidemiologic, bronhodilatatoare, bronhopneumopatia obstructivă cronică |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-83145</cfResPublId> <cfResPublDate>2019-08-21</cfResPublDate> <cfVol>53</cfVol> <cfIssue>2</cfIssue> <cfStartPage>74</cfStartPage> <cfISSN>1857-0461</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/83145</cfURI> <cfTitle cfLangCode='RU' cfTrans='o'>Фармакоэпидемиологическое исследование бронходилататоров при хронической обструктивной болезни легких в г. Кишиневe и г. Курскe</cfTitle> <cfKeyw cfLangCode='RU' cfTrans='o'>pharmacoepidemiological study; bronchodilator; chronic obstructive bronchopneumopathy; studiu farmacoepidemiologic; bronhodilatatoare; bronhopneumopatia obstructivă cronică</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>The pharmacoepidemiological study demonstrated that bronchodilator preparations were prescribed for the treatment of chronic obstructive bronchopneumopathy in accordance with national and international recommendations. Salbutamol or fenoterol was administered in case of disease exacerbations. While long-acting beta2-adrenomimetics, M-colinoblocks and inhaled glucocorticoids were used in the treatment of stable forms of chronic obstructive pulmonary disease. Fixed combinations such as beta-2-adrenomimetics with long-lasting M-colinoblocks, long-lasting beta-2 adrenomimetics with inhaled glucocorticoids, beta-2-adrenomimetics with long-lasting M-colinoblocks with inhaled glucocorticoids were also used. These drugs were prescribed as original or generic preparations, depending on availability in the pharmaceutical market.</p></cfAbstr> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Studiul farmacoepidemiologic, efectuat în perioada februarie–septembrie 2018 în orașele Chișinău (Republica Moldova) și Kursk (Federația Rusă), a demonstrat că pentru tratamentul bronhopneumopatiei obstructive cronice s-au prescris preparatele bronhodilatatoare în conformitate cu recomandările naţionale şi internaţionale. În cazul exacerbărilor maladiei se administrau salbutamolul sau fenoterolul. În tratamentul formelor stabile ale bronhopneumopatiei obstructive cronice se utilizau în monoterapie beta-2-adrenomimeticele de durată lungă, M-colinoblocantele şi glucocorticoizii inhalatorii. De asemenea, se utilizau şi combinaţiile fixe, precum: beta-2-adrenomimetice cu M-colinoblocante de durată lungă, beta-2-adrenomimetice de durată lungă cu glucocorticoizi inhalatori, beta-2-adrenomimetice cu M-colinoblocante de durată lungă cu glucocorticoizi inhalatori. Aceste medicamente erau prescrise sub formă de preparate originale sau generice, în funcţie de disponibilul pe piaţa farmaceutică.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11721</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-66379</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-52415</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-10648</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-22820</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-13831</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-66380</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-56653</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-83145</cfFedIdId> <cfFedId>10.5281/zenodo.3364337</cfFedId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11721</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11721-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Ghicavîi</cfFamilyNames> <cfFirstNames>Victor</cfFirstNames> <cfFamilyNames>Гикавый</cfFamilyNames> <cfFirstNames>Виктор</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-66379</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-66379-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Клюева</cfFamilyNames> <cfFirstNames>Елена</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-52415</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-52415-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Поветкин</cfFamilyNames> <cfFirstNames>Сергей</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-10648</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-10648-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Bachinsky</cfFamilyNames> <cfFirstNames>N.G.</cfFirstNames> <cfFamilyNames>Бачинский</cfFamilyNames> <cfFirstNames>Николай</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-22820</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-22820-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Podgursky</cfFamilyNames> <cfFirstNames>L. A.</cfFirstNames> <cfFamilyNames>Подгурски</cfFamilyNames> <cfFirstNames>Лилия</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-13831</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-13831-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Цуркан</cfFamilyNames> <cfFirstNames>Лучия</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-66380</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-66380-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Польшакова</cfFamilyNames> <cfFirstNames>Ирина</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-56653</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-56653-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-08-21T24:00:00</cfStartDate> <cfFamilyNames>Киану</cfFamilyNames> <cfFirstNames>Марин</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>